Treatment and follow-up of children with cerebrotendinous xanthomatosis

European Journal of Pediatrics

Volumn 157, Issue 4, 1998, Pages 313-316

  Van Heijst, A F J ^a   Verrips, A ^a   Wevers, R A ^a   Cruysberg, J R M ^a   Renier, W O ^a   Tolboom, J J M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cerebrotendinous xanthomatosis; Clinical spectrum; Follow up; Treatment

Indexed keywords

CHENODEOXYCHOLIC ACID;

ADOLESCENT; ADULT; ARTICLE; BILE SECRETION; CEREBROTENDINOUS XANTHOMATOSIS; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; INTELLIGENCE QUOTIENT; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CHENODEOXYCHOLIC ACID; CHILD; CHOLESTANOL; CHOLESTANOLS; CHOLESTEROL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NEUROLOGIC EXAMINATION; XANTHOMATOSIS, CEREBROTENDINOUS;

EID: 0031955919     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004310050818     Document Type: Article

References (29)

1. Argov Z, Soffer D, Eisenberg S, Zimmerman Y (1986) Chronic demyelinating peripheral neuropathy in cerebrotendinous xanthomatosis. Ann Neurol 20:89-91
2. Arlazoroff A, Roitherg B, Werber E, Shidlo R, Berginer VM (1991) Epileptic seizure as a presenting symptom of cerebrotendinous xanthomatosis. Epilepsia 32:657-661
3. Berginer VM, Salen G, Shefer S (1984) Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid. N Engl J Med 311:1649-1652
4. Berginer VM, Berginer J, Korezyn AD, Tadmor R (1994) Magnetic resonance imaging in cerebrotendinous xanthomatosis: a prospective clinical and neuroradiological study. J Neurol Sci 122:102-108
5. Björkhem I, Boberg KM (1995) Inborn errors in bile acid biosynthesis and storage of sterols other than cholesterol. In: Scriver C, Beaudet AL, Sly WS, Valle D (eds). The metabolic and molecular basis of inherited disease. McGraw-Hill, New York, pp 2273-2299
6. Bogaert L, Scherer H, Epstein E (1937) Une forme cérébrale de la cholestérinose généralisée, Paris:Masson et Cie
7. Brautbar C, Yehuda O, Eisenberg S, Cohen N, Amar A, Sharon R, Fried K, Aghasi M, Cohen T (1983) Study of a family with cerebrotendinous xanthomatosis. No HLA linkage, but an informative recombination between HLA-B and Bf. Tissue Antigens 21:233-237
8. Bruininks RH (1978) Bruininks-Oseretsky test of motor proficiency. examiners manual. American Guidance Service. Circle Pines, MN
9. Cruysberg JR, Wevers RA, Tolboom JJ (1991) Juvenile cataract associated with chronic diarrhea in pediatric cerebrotendinous xanthomatosis. Am J Ophthalmol 112:606-607
10. Cruysberg JR, Wevers RA, Engelen BGM, Pinckers A, Spreeken A, Tolboom JJ (1995) Ocular and systemic manifestations of cerebrotendinous xanthomatosis. Am J Ophthalmol 120: 597-604
11. Farpour H (1990) [Zonular juvenile cataract and cerebrotendinous xanthomatosis]. Klin Monatsbl Augenheilkd 196:407-410
12. Farpour H, Mahloudji M (1975) Familial cerebrotendinous xanthomatosis. Report of a new family and review of the literature. Arch Neurol 32:223-225
13. Hokezu Y, Kuriyuma M, Kubota R, Nakagawa M, Fujiyama J. Osame M (1992) Cerebrotendinous xanthomatosis: cranial CT and MRI studies in eight patients. Neuroradiology 34:308-312
14. Knipscheer HC, Boelen CCA, Kastelein JJP, Diermen DE van, Groenemeijer BE, Ende A van den, Büller HR, Bakker HD (1996) Short-term efficacy and safety of Pravastatin in 72 children with hypercholesterolemia. Pediatr Res 39:867-871
15. Koopman BJ, Wolthers BG, Molen JC van der, Waterreus RJ (1985) Bile acid therapies applied to patients suffering from cerebrotendinous xanthomatosis. Clin Chim Acta 152:115-122
16. Kuritzky A, Berginer VM, Korczyn AD (1979) Peripheral neuropathy in cerebrotendinous xanthomatosis. Neurology 29:880-881
17. Kuriyama M, Fujiyama J, Yoshidome H, Takenaga S, Matsumuro K, Kasama T, Fukuda K, Kuramoto T, Hoshita T, Seyama Y, Okatu Y, Osame M (1991) Cerebrotendinous xanthomatosis: clinical and biochemical evaluation of eight patients and review of the literature. J Neurol Sci 102:225-232
18. Kuriyama M, Tokimura Y, Fujiyama J, Utatsu Y, Osame M (1994) Treatment of cerebrotendinous xanthomatosis: effects of chenodeoxycholic acid, pravastatin, and combined use. J Neurol Sci 125:22-28
19. Leitersdorf E, Meiner V (1994) Cerebrotendinous xanthomatosis. Curr Opin Lipidol 5:138-142
20. Leitersdorf E, Safadi R, Meiner V, Reshef A, Björkhem I, Friedlander Y, Morkos S, Berginer VM (1994) Cerebrotendinous xanthomatosis in the Israeli Druze: molecular genetics and phenotypic characteristics. Am J Hum Genet 55:907-915
21. Lewis B, Mitchell WD, Marenah CB, Cortese C, Reynolds EH, Shakir R (1983) Cerebrotendinous xanthomatosis: biochemical response to inhibition of cholesterol synthesis. Br Med J Clin Res Ed 287:21-22
22. Nakamura T, Matsuzawa Y, Takemura K, Kubo M, Miki H, Tarui S (1991) Combined treatment with chenodeoxycholic acid and pravastatin improves plasma cholestanol levels associated with marked regression of tendon xanthomas in cerebrotendinous xanthomatosis. Metabolism 40:741-746
23. Oftebro H, Björkhem I, Stormer FC, Pedersen JI (1981) Cerebrotendinous xanthomatosis: defective liver mitochondrial hydroxylation of chenodeoxycholic acid precursors. J Lipid Res 22:632-640
24. Pedley TA, Emerson RG, Warner CL, Rowland LP, Salen G (1985) Treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid. Ann Neurol 18:517-518
25. Peynet J, Laurent A, De Liege P, Lecoz P, Gambert P, Legrand A, Mikol J, Warnet A (1991) Cerebrotendinous xanthomatosis: treatments with simvastatin, lovastatin, and chenodeoxycholic acid in 3 siblings. Neurology 41:434-436
26. Van Heijst AFJ, Wevers RA, Tangerman A, Cruysberg JRM (1996) Chronic diarrhoea as a dominating symptom in two children. Acta Paediatr 85:932-936
27. Wechsler DA (1974) WISC-R Manual for the Wechsler Intelligence Scale for Children-Revised. Psychological Corporation, New York
28. Wolthers BG, Volmer M, Molen J van der, Koopman BJ, Jager AE de, Waterreus RJ (1983) Diagnosis of cerebrotendinous xanthomatosis (CTX) and effect of chenodeoxycholic acid therapy by analysis of urine using capillary gas chromatography. Clin Chim Acta 131:53-65
29. Wolthers BG, Walrecht HT, Molen JC van der, Nagel GT, Van Doormaal JJ, Wijnandts PN (1991) Use of determinations of 7-lathosterol (5 alpha-cholest-7-en-3 beta-ol) and other cholesterol precursors in serum in the study and treatment of disturbances of sterol metabolism, particularly cerebrotendinous xanthomatosis. J Lipid Res 32:603-612